In this edition:
ALLEGRO: ritlecitinib in alopecia areata
ICONIC-ADVANCE 1 & 2: icotrokinra vs. placebo/deucravacitinib in plaque psoriasis
Dupilumab dose tapering in paediatric atopic dermatitis
Long-term psychological impacts of paediatric/adolescent atopic dermatitis
Temtokibart in atopic dermatitis
REZOLVE AD: rezpegaldesleukin in atopic dermatitis
ROCKET-Ignite: rocatinlimab in atopic dermatitis
APEX: a novel, extended half-life anti-IL-13 antibody in atopic dermatitis
Izokibep in hidradenitis suppurativa
STOP-HS1 & -HS2: povorcitinib in hidradenitis suppurativa
Please login below to download this issue (PDF)